Insider Transactions in Q1 2025 at Aura Biosciences, Inc. (AURA)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 18
2025
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
20,221
-4.02%
|
$141,547
$7.75 P/Share
|
Feb 18
2025
|
Janet Jill Hopkins Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,534
-0.93%
|
$17,738
$7.75 P/Share
|
Feb 18
2025
|
Amy Elazzouzi Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,404
-1.68%
|
$9,828
$7.75 P/Share
|
Feb 18
2025
|
Mark Plavsic Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,151
-1.02%
|
$15,057
$7.75 P/Share
|
Feb 03
2025
|
Amy Elazzouzi Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
45,240
+35.09%
|
-
|
Feb 03
2025
|
Conor Kilroy |
BUY
Grant, award, or other acquisition
|
Direct |
90,475
+32.67%
|
-
|
Feb 03
2025
|
Janet Jill Hopkins Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,635
+30.7%
|
-
|
Feb 03
2025
|
Mark Plavsic Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,475
+29.95%
|
-
|
Feb 03
2025
|
Pinos Elisabet De Los |
BUY
Grant, award, or other acquisition
|
Direct |
194,320
+27.88%
|
-
|
Jan 21
2025
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct |
15,955
-4.98%
|
$111,685
$7.67 P/Share
|
Jan 21
2025
|
Amy Elazzouzi Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,001
-2.54%
|
$7,007
$7.67 P/Share
|